TPG Group Holdings (SBS) Advisors’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$8.79M	Hold	1,885,939	–	–	0.09%	38
2021 Q2	$13.3M	Hold	1,885,939	–	–	0.09%	39
2021 Q1	$11.1M	Hold	1,885,939	–	–	0.13%	41
2020 Q4	$8.69M	Hold	1,885,939	–	–	0.1%	36
2020 Q3	$7.34M	Hold	1,885,939	–	–	0.13%	37
2020 Q2	$54.2M	Hold	1,885,939	–	–	0.96%	25
2020 Q1	$40.6M	Hold	1,885,939	–	–	0.94%	24
2019 Q4	$37.1M	Hold	1,885,939	–	–	0.55%	31
2019 Q3	$28.3M	Buy	+1,885,939	New	+$29.3M	0.42%	35

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's STSA Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Satsuma Pharmaceuticals, Inc. Common Stock (STSA) position steady in Q3 2021 at 1,885,939 shares worth $8.79M. The position accounts for 0.09% of the portfolio, ranked #38.

TPG Group Holdings (SBS) Advisors first reported a position in STSA in Q3 2019 and has held it in 9 quarters since. The position peaked at $54.2M in Q2 2020. 45 funds tracked by Wall St. Rank hold STSA as of Q3 2021.

TPG Group Holdings (SBS) Advisors held 1,885,939 shares of Satsuma Pharmaceuticals, Inc. Common Stock worth $8.79M as of Q3 2021.
TPG Group Holdings (SBS) Advisors left its Satsuma Pharmaceuticals, Inc. Common Stock share count unchanged in Q3 2021.
Satsuma Pharmaceuticals, Inc. Common Stock made up 0.09% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #38 holding.
TPG Group Holdings (SBS) Advisors first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2019 and has held it in 9 quarters since.
TPG Group Holdings (SBS) Advisors's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $54.2M in Q2 2020.
45 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.